Episode 1 (December 8, 2023): Nevan Krogan (UCSF) mapping autism pathways; Nvidia’s latest AI partnership; CAR-T regulations; epigenome editing; mRNA therapeutics.
References to the GEN stories, media and other items discussed in this episode of Touching Base:
Autism’s Molecular Mechanisms Uncovered through Protein-Protein Interaction Network
By Julianna Lemieux, GEN, December 5, 2023.
Rhapsody in B: Tune Therapeutics Presents Data for Hepatitis B Epigenetic Silencer
By Jonathan Grinstein, GEN Edge, December 6, 2023.
Nvidia Looks to Genentech for its Next Leap in AI Drug Discovery
By Alex Philippidis, GEN Edge, November 28, 2023.
StockWatch: CAR-T Shares Mostly Flat as FDA Probes Risk of New Cancers
By Alex Philippidis, GEN, December 1, 2023
Perfect Pitch: Genome Editing Pioneer Fyodor Urnov on Commercializing CRISPR Therapies and Epigenomic Tuning {VIDEO}
GEN Edge, August 30, 2023
Press release: John Crowley appointed President & CEO of BIO
Biotechnology Innovation Organization
BIO CEO Rachel King Outlines Industry’s Challenges on “Close to the Edge”
GEN multimedia, April 26, 2023
The First CRISPR Drug: Vertex Pharmaceuticals’ Casgevy Wins U.K. Approval for Sickle Cell Disease
GEN, November 16, 2023
To access all episodes of Touching Base click here.
